MyAverix Finance
US · Healthcare
Akebia Ther (AKBA)
Drug Manufacturers - Specialty & Generic
Akebia Ther (AKBA) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for AKBA
Akebia Ther (AKBA) — FAQ
What is AKBA's P/E ratio?
The price-to-earnings (P/E) ratio for Akebia Ther (AKBA) is 18.00 (data as of 2026-03-23).
Does Akebia Ther pay a dividend?
Dividend yield is not available in the current snapshot for Akebia Ther (AKBA). Check the MyAverix Finance app for the latest dividend data.
What sector is Akebia Ther in?
Akebia Ther (AKBA) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is AKBA listed on?
AKBA is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.